Evaluation of clinical usefulness of proton pump inhibitor after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal cancer: A multicenter prospective randomized controlled trial
Not Applicable
- Conditions
- early esophageal cancer
- Registration Number
- JPRN-UMIN000002544
- Lead Sponsor
- Kyoto University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 220
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with active peptic ulcer in stomach or duodenum. 2. Patients with active concomitant cancers. 3. Patients requiring systemic steroids medication. 4. Patients with continuous systemic medication of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). 5. Patients who cannot discontinue anticoagulant drug or antiplatelet drug before endoscopic treatment. 6. Patients with severe mental disease or psychotic manifestation. 7.Patients who have been judged as inappropriate for this study for any reasons by the concerning investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method